41.87% | % of shares held by all insiders |
30.23% | % of shares held by institutions |
52.01% | % of float held by institutions |
53 | Number of institutions holding shares |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
BVF Inc. | 14,571,236 | 30 Dec 2023 | 14.73% | 35,116,680 |
Avidity Partners Management, LP | 4,469,080 | 30 Dec 2023 | 4.52% | 10,770,483 |
Blackrock Inc. | 2,418,020 | 30 Dec 2023 | 2.44% | 5,827,428 |
Redmile Group, LLC | 2,000,000 | 30 Dec 2023 | 2.02% | 4,820,000 |
Morgan Stanley | 1,757,240 | 30 Dec 2023 | 1.78% | 4,234,948 |
Platinum Investment Management Ltd | 1,515,585 | 30 Dec 2023 | 1.53% | 3,652,559 |
Wells Fargo & Company | 1,148,691 | 30 Dec 2023 | 1.16% | 2,768,345 |
Stempoint Capital LP | 434,588 | 30 Dec 2023 | 0.44% | 1,047,357 |
Renaissance Technologies, LLC | 417,579 | 30 Dec 2023 | 0.42% | 1,006,365 |
Deutsche Bank Aktiengesellschaft | 253,375 | 30 Dec 2023 | 0.26% | 610,633 |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
BlackRock Health Sciences Term Trust | 752,390 | 30 Dec 2023 | 0.76% | 1,813,259 |
iShares Biotechnology ETF | 429,040 | 28 Feb 2024 | 0.43% | 1,033,986 |
Blackrock Health Sciences Trust | 78,180 | 30 Dec 2023 | 0.08% | 188,413 |
Pacific Select Fund-Health Sciences Portfolio | 53,150 | 30 Dec 2023 | 0.05% | 128,091 |
Fidelity NASDAQ Composite Index Fund | 45,869 | 30 Jan 2024 | 0.05% | 110,544 |
Fidelity Select Portfolios - Biotechnology | 27,202 | 30 Jan 2024 | 0.03% | 65,556 |
DFA U.S. Vector Equity Portfolio | 15,821 | 30 Jan 2024 | 0.02% | 38,128 |
DFA U.S. Micro Cap Series | 10,530 | 30 Jan 2024 | 0.01% | 25,377 |
DFA U.S. Core Equity 2 Portfolio | 8,197 | 30 Jan 2024 | 0.01% | 19,754 |
ProShares Tr-Ultra Nasdaq Biotechnology Fd | 5,991 | 28 Feb 2024 | 0.01% | 14,438 |